COVID-19 Antigen Test Kit (Dry Fluorescence Immunoassay)
Product Description
1. DSC utilizes an advanced methodology called Time-resolved Fluorescence Immunoassay (TRFIA) Method. TRFIA is super-sensitive detection technique characterized by specific fluorescence of rare earth ions. It is not only highly sensitive, but also overcomes the instability of enzyme marker and is the best choice for immunological detection. The high fluorescence intensity and long life of labeled ionic chelates are beneficial to eliminate the influence of fluorescent substances in samples and environment on the test results.
2. Analyzer Introduction: Analyzer uses the advanced method of Time-resolved Fluorescence Immunoassay (TRFIA), for the in-vitro quantitative detection of bio-markers for Diabetes Mellitus, Inflammation, Cardiovascular Diseases, Hormone, Gastric Diseases, Renal Diseases, Tumor, etc.
3. Application: Laboratory, ER, Cardiology, ICU, Respiratory, Pediatrics, etc.
COVID-19 Antigen Test Kit (Dry FluorescenceImmunoassay)is intend ed for the detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of the onset of sympt oms.
● A recommendation that the kit and analyzer are intended for use by healthcare and laboratory professionals.
● For professional use only.
|
COVID-19 Antigen Test Kit (Dry FluorescenceImmunoassay) |
|
|
PACKAGE SPECIFICATION |
25Test/Kit |
|
REACTION TIME |
15 minutes |
|
SAMPLE TYPE |
Human Nasal Swab |
|
METHODOLOGY |
Time-resolved Fluorescence Immunoassay |
|
STORAGE |
4-30℃ |
Test Principle
COVID-19 Antigen Test Kit (Dry Fluorescence Immunoassay) uses the p rinciple of antigen-antibody reaction. The testing specimen will migra te forward due to capillary action, then the analyte of the specimen will combine with antibody which is attached to fluorescence microsph eres. This marked complex is attached to the detection area of immobilized antibody and the other fluorescence microspheres are attached to the control area.
When the test strip is inserted into the analyzer, the analyzer automa tically scans two ribbons and detected the fluorescence intensity of the composite emission from the testing area and the control area. The ratio of the two fluorescence values was used to calculate the content of the detected substances.
Operating Mode
Application Analyzer
More Test Items Available
|
Category |
Test Item |
Category |
Test Item |
|
COVID-19 |
IgM/IgG |
Hormone |
TT3 |
|
Diabetes |
HbA1c |
TT4 |
|
|
Inflammation |
CRP |
TSH |
|
|
PCT |
25-OH-VD |
||
|
SAA |
β-HCG |
||
|
SAA/CRP |
LH |
||
|
PCT/CRP |
FSH |
||
|
Cardiac |
CK-MB |
PRL |
|
|
cTnI |
AMH |
||
|
Myo |
Gastric Function |
PGI/PGII
|
|
|
cTnI/CK-MB/Myo |
Tumor |
PSA |
|
|
NT-proBNP |
|
|
|
|
D-Dimer |
|
|
|
|
H-FABP |
|
